In the first pre-symptomatic stage, AβPP-derived Aβ accumulates to critical levels in a decades-long process that induces the activation of the second, devastating symptomatic AD stage that is anchored and driven by an agent which is independent of AβPP and sustains and perpetuates its own production [37,38]. The gene discussed is APP; the disease is Alzheimer disease.